欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
NO/H/0102/002
药品名称
Lisinopril/Hydrochlorotiazide Alpharma 20 mg/12,5 mg
活性成分
hydrochlorothiazide 12.5 mg
lisinopril 20.0 mg
剂型
Tablet
上市许可持有人
Actavis Group PTC ehf Hafnarfjordur Iceland
参考成员国 - 产品名称
Norway (NO)
互认成员国 - 产品名称
许可日期
2002/07/11
最近更新日期
2024/06/27
药物ATC编码
C09BA03 lisinopril and diuretics
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Initial Application
TypeLevel3:
Generic Article 4.8(a)(iii), first paragraph
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final SPC
|
PI_Lisinopril_DK_H_0314_02_04_V045_v4_2_Day 40_030717_CL
Date of last change:2024/09/06
Final SPC
|
PI_Lisinopril_HCT_DK_H_0765_01_02_V022_v1_2_Day 40_030717_CL
Date of last change:2024/09/06
Final SPC
|
SmPC_Lisinopril_HCT_DK_H_0473_01_03_V050_v5_1_20170222_CL
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase